Stagliano Nancy reported ETRA

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001817449-26-000009

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 21, 2026

Published

Sep 21, 2026

Ingested by INSIDER

Nov 5, 02:16 UTC

Last re-read

Nov 5, 02:16 UTC

Extracted facts

Filer

Stagliano Nancy

Role

Director

Transaction

Derivative conversionAs filed: “C”

Asset

Electra Therapeutics, Inc. — Series A Convertible Preferred Stock

Ticker

ETRA

Shares

255.6K

Execution date (reported)

Sep 21, 2026

Owned after transaction

0 shares

Days from execution to publication

0

What this establishes

Stagliano Nancy filed this Form 4 reporting a derivative conversion of ETRA on Sep 21, 2026. It became public on Sep 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Stagliano Nancycik:0001817449

Issuer

Electra Therapeutics, Inc.cik:0002088082

Revision history · 0

No field has changed since this record was first ingested.